If you’ve been researching fertility or have had a conversation with a reproductive endocrinologist, you may have encountered the term AMH — anti-Müllerian hormone. This hormone has become one of the most commonly discussed markers of ovarian reserve, and for women over 35 who are thinking about fertility, understanding what AMH levels indicate — and what they don’t — can be genuinely valuable.
AMH testing has grown significantly in availability and use over the past decade, and with that growth has come both helpful information and, sometimes, unnecessary anxiety. A low AMH result can feel alarming, particularly when encountered alongside general messaging about fertility decline after 35. But AMH is a nuanced marker, and its interpretation requires context that isn’t always provided in a brief lab report or a quick online search.
This article aims to provide clear, evidence-informed context about AMH after 35 — what it measures, what the research says about its predictive value, its limitations, and why a conversation with a reproductive healthcare provider is essential for meaningful interpretation.
What AMH Actually Measures
Anti-Müllerian hormone is produced by cells in the small, developing follicles in the ovaries. Because AMH production is proportional to the number of these small follicles, it serves as a proxy measure of ovarian reserve — broadly, the quantity of eggs remaining.
Unlike many other hormones associated with the menstrual cycle, AMH levels are relatively stable throughout the cycle, which means a test can be taken at any point in the month without timing concerns. This practical advantage has contributed to its widespread adoption as a fertility screening tool.
According to research from the American College of Obstetricians and Gynecologists, AMH is considered one of the most reliable markers currently available for assessing ovarian reserve. However, the organization and fertility specialists consistently note that AMH is just one piece of a larger picture that includes age, antral follicle count (AFC), other hormone levels, and individual health history.
How AMH Levels Change With Age
AMH levels naturally decline with age, reflecting the natural reduction in the pool of small follicles that occurs as part of normal reproductive aging. This decline is gradual but becomes more pronounced through the 30s and 40s.
Research has documented significant variation in AMH levels among women of the same age. Two 38-year-old women may have dramatically different AMH values, both of which fall within ranges seen in fertile women who go on to conceive. This variability is one of the key reasons that AMH values cannot be interpreted in isolation from age and other clinical factors.
For women experiencing irregular cycles related to perimenopause, AMH testing may be one component of an evaluation to understand where they are in the transition — though again, interpretation requires professional context.
What AMH Can and Cannot Predict
Understanding the genuine strengths and limitations of AMH testing is important for making sense of results without drawing conclusions that the test cannot actually support.
What AMH Can Help Indicate
AMH is reasonably well-validated as a predictor of ovarian response to hormonal stimulation — relevant for women considering IVF or other assisted reproductive technologies. Women with lower AMH tend to produce fewer eggs in response to stimulation, which affects protocol planning for fertility treatments.
AMH can also provide some indication of the likely pace of ovarian aging and, in conjunction with other markers, help estimate roughly how much time may remain before the natural decline in fertility accelerates more steeply. This kind of information can be useful for family planning discussions.
What AMH Cannot Predict
AMH has important limitations that are sometimes underemphasized. Research does not support using AMH alone as a definitive predictor of whether an individual woman will or will not conceive — naturally or through fertility treatment. Studies have found that women with low AMH do conceive naturally and through IVF, and women with apparently normal AMH for their age can experience fertility challenges for other reasons.
Perhaps most importantly, AMH does not measure egg quality — only quantity. Since egg quality is the primary factor that declines with age and the primary driver of age-related fertility changes, AMH’s limitation in this area is clinically significant. A normal-seeming AMH does not guarantee good egg quality, and low AMH does not necessarily mean egg quality is poor.
Interpreting AMH Results: Why Professional Context Matters
Laboratory reference ranges for AMH can vary between testing facilities, and “normal” values are typically age-stratified. A value that would be considered low for a 28-year-old may be entirely expected for a 40-year-old.
When interpreting AMH results, reproductive endocrinologists typically consider:
- Antral follicle count (AFC) — a transvaginal ultrasound assessment of the number of small follicles visible at a given point in the cycle, which provides complementary information to AMH
- FSH and estradiol levels — typically measured on cycle day 3, these provide additional context about hormonal signaling
- Age — the single strongest predictor of natural fertility, providing the essential backdrop against which all other markers must be interpreted
- Clinical history — including pregnancy history, menstrual cycle characteristics, overall health, and other relevant factors
A single AMH result without this context is genuinely difficult to interpret meaningfully, which is why results shared without professional guidance can cause confusion or unnecessary distress.
Fertility Preservation Decisions and AMH
For women who are not yet ready to conceive but are considering the future, AMH testing is sometimes discussed in the context of egg freezing decisions. The reasoning is that lower AMH may suggest a faster pace of ovarian aging, potentially making earlier action more relevant.
However, the decision about whether and when to pursue fertility preservation is complex and involves many factors beyond AMH levels — including personal circumstances, values, the realities of egg freezing success rates (which vary with age at freezing), and financial considerations. This is a decision best made in thorough consultation with a reproductive endocrinologist who can provide personalized information.
Frequently Asked Questions
If my AMH is low, does that mean I can’t get pregnant?
Low AMH does not mean that pregnancy is impossible, either naturally or through fertility treatment. Research has documented pregnancies — including spontaneous conceptions — in women with low AMH values. However, lower AMH may indicate reduced ovarian reserve, which can affect the pace at which fertility declines and response to hormonal stimulation if IVF is pursued. Working with a reproductive endocrinologist can help you understand what low AMH means in the context of your individual situation.
Can AMH levels be increased?
Current evidence does not support the idea that AMH levels can be significantly increased through supplements, diet, or other interventions. Ovarian reserve represents a biological reality related to the quantity of eggs available, and there is no established method of increasing this pool. Some research has explored the potential effects of various supplements on AMH, but findings are preliminary and no intervention currently has strong evidence of effectiveness in clinical practice.
How often should AMH be tested?
There is no universal standard for how often AMH should be retested, and this decision is best made with a healthcare provider based on your individual circumstances and goals. Repeat testing within a few months may not provide meaningful new information, as changes in AMH tend to occur over a longer timeframe. If you’re actively working with a reproductive endocrinologist, they can guide appropriate timing for follow-up testing.
Is AMH testing covered by insurance?
Coverage varies significantly by insurance plan, location, and clinical indication. In some cases, AMH testing ordered as part of an infertility evaluation may be covered; testing ordered for general information or fertility preservation planning may not be. Checking with your insurance provider and healthcare team about coverage and cost before ordering testing is advisable.
Key Takeaways
- AMH is a marker of ovarian reserve (egg quantity), not egg quality, and is one of several tools used to assess fertility potential
- AMH levels naturally decline with age, but there is significant variation between individuals of the same age
- AMH cannot reliably predict whether an individual will conceive and should always be interpreted alongside age, AFC, and other clinical factors by a qualified provider
- Low AMH does not preclude pregnancy; conversely, normal AMH does not guarantee fertility, as egg quality — the primary age-related fertility factor — is not measured by AMH
- Decisions about fertility treatment or preservation based on AMH results are best made through detailed consultation with a reproductive endocrinologist
Medical Disclaimer
This content is for informational purposes only and does not constitute medical advice. Individual health situations vary significantly. Always consult a qualified healthcare provider before making decisions related to your health, fertility, or pregnancy.
About the Author
Emily Carter is a women’s health writer focused on fertility, pregnancy after 35, and sleep changes in midlife. She writes research-informed, non-alarmist content to help women navigate reproductive and hormonal transitions with clarity and confidence.